Please login to the form below

Not currently logged in
Email:
Password:

Shingrix

This page shows the latest Shingrix news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s Corsico to be new GSK drug dev leader

Boehringer’s Corsico to be new GSK drug dev leader

The company achieved three major approvals last year - shingles vaccine Shingrix, respiratory treatment Trelegy Ellipta and HIV combination Juluca.

Latest news

  • The year of the blockbuster The year of the blockbuster

    In the EU, the EMA granted accelerated assessment. Shingrix (Zoster vaccine recombinant, adjuvanted) from GlaxoSmithKline:Shingrix was approved in the  US in October 2017 and was launched nationwide in March 2018, ... Shingrix is projected to become the

  • GSK’s vaccines president Debruyne heads for the exit GSK’s vaccines president Debruyne heads for the exit

    His responsibilities stretched to preparing the launch of Shingrix, GSK’s tipped blockbuster-in-waiting shingles vaccine, which pulled in sales of £110m ($150m) for the company in the first quarter

  • GSK gets maintenance indication for Trelegy GSK gets maintenance indication for Trelegy

    Among GSK’s other critical growth products shingles vaccine Shingrix made £110m in the first quarter - stronger than expected - while its HIV portfolio grew 6% to £1.05bn, which some analysts

  • Gilead’s triple HIV drug approval prompts GSK lawsuit Gilead’s triple HIV drug approval prompts GSK lawsuit

    vaccine Shingrix and recently-approved triple therapy for chronic obstructive pulmonary disorder (COPD) Trelegy - as it faces the imminent threat of generic competition to its big-selling respiratory drug Advair (salmeterol ... Shingrix was approved in

  • GSK’s ViiV gets US okay for two-drug HIV regimen GSK’s ViiV gets US okay for two-drug HIV regimen

    It’s an important drug for GSK, and along with shingles vaccine Shingrix and recently-approved triple therapy for chronic obstructive pulmonary disorder (COPD) Trelegy.

More from news
Approximately 8 fully matching, plus 14 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics